Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies directed against programmed death-1 protein and their use in medicine

Monoclonal antibodies directed against programmed death-1 protein and their use in medicine

US Patent 11932693 · Granted Mar 19, 2024

Estimated economic value: $73,230,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for reducing immunogenicity of RNA2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Binding agents that bind OX40 (CD134) and method of use thereof to treat disease2025
Tumor antigens for determining cancer therapy2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Antibodies capable of binding to OX40, variants thereof and uses thereof2025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025
Binding agents binding to EpCAM and CD1372025